Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print Cited Medium: Print ISSN: 0019-2805 (Print) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE

Original Publication: Oxford : Blackwell Scientific Publications

Antigens, Protozoan/*immunology ; Arachidonic Acid/*metabolism ; Entamoeba histolytica/*immunology ; Liver Abscess, Amebic/*immunology ; Macrophages/*metabolism; Animals ; Cells, Cultured ; Dinoprostone/biosynthesis ; Gerbillinae ; Male ; Peritoneal Cavity/cytology ; SRS-A/biosynthesis

Entamoeba histolytica infections are associated with a state of transient suppression of cell-mediated immunity. Macrophages, the most important cells in host defence and control of invasive amoebiasis, in infected animals have been found to be deficient in effector functions and accessory cell potential. However, little is known of the cellular mechanisms responsible for the down-regulation. This study investigated whether macrophage dysfunction in amoebiasis is associated with altered macrophage arachidonic acid (AA) metabolism. Resident peritoneal macrophages (PMO) from naive gerbils produced enhanced levels of prostaglandin E2 (PGE2) and leukotriene C4 (LTC4) in response to live E. histolytica trophozoites, to diffusible excretory/secretory products released from live amoebae in millicells and to freeze-thawed soluble amoebic proteins that were inhibitable by indomethacin (INDO) and nordihydroguaiaretic acid (NDGA), respectively. In contrast to PMO from naive gerbils, PMO from animals with amoebic liver abscesses at 10, 20 and 30 days post-infection (p.i.) released high basal levels of PGE2 and LTC4. In response to zymosan stimulation, PMO from infected animals produced two- and fourfold less PGE2 and LTC4, respectively, as compared to uninfected controls. AMO showed high constitutive basal release of PGE2 and LTC4. In response to amoebic and zymosan stimulation, AMO at 10 days p.i. produced significantly higher levels of PGE2 than AMO at 20 days p.i., while AMO at 30 days p.i. were refractory to stimulation to produce higher than basal levels of PGE2. Early (10 days) and late (20-30 days) AMO were refractory to amoebic and zymosan stimulation for enhanced LTC4 release. Pretreatment of AMO with AA substrate restored optimal PGE2 and LTC4 biosynthesis, but the cells were generally unresponsive to zymosan stimulation to produce augmented levels of LTC4. These results strongly suggest that intrinsic or secreted products or both from E. histolytica can induce profound alteration of eicosanoid formation in cyclooxygenase and lipoxygenase pathways in macrophages from naive and infected animals and that AA metabolism by AMO is sequentially modified during the course of the disease.

J Exp Med. 1986 Mar 1;163(3):536-49. (PMID: 2869098)
J Exp Med. 1982 Apr 1;155(4):1148-60. (PMID: 6801185)
Infect Immun. 1985 Sep;49(3):828-32. (PMID: 2863217)
J Immunol. 1986 Apr 1;136(7):2633-9. (PMID: 2869086)
J Cell Biochem. 1985;29(4):299-308. (PMID: 2868017)
J Immunol. 1986 Nov 15;137(10):3053-6. (PMID: 2877026)
J Infect Dis. 1985 May;151(5):816-22. (PMID: 2859339)
Prog Allergy. 1988;44:153-71. (PMID: 2849773)
J Immunol. 1987 Feb 15;138(4):1074-81. (PMID: 3027169)
Prog Allergy. 1988;44:1-214. (PMID: 3144714)
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9655-9. (PMID: 3099288)
J Immunol. 1986 Dec 15;137(12):3915-20. (PMID: 3097136)
J Immunol. 1986 Jan;136(1):186-92. (PMID: 3079606)
Infect Immun. 1989 Jun;57(6):1750-6. (PMID: 2542164)
J Biol Chem. 1989 Feb 15;264(5):3007-12. (PMID: 2536731)
J Immunol. 1989 Oct 1;143(7):2127-32. (PMID: 2506277)
Agents Actions. 1989 Jan;26(1-2):15-21. (PMID: 2653001)
Infect Immun. 1988 Dec;56(12):3126-31. (PMID: 2903124)
Lab Invest. 1988 Feb;58(2):119-21. (PMID: 3276957)
Clin Exp Immunol. 1984 Dec;58(3):548-56. (PMID: 6391763)
Am J Pathol. 1984 Oct;117(1):71-80. (PMID: 6385727)
J Immunol. 1985 Jan;134(1):556-63. (PMID: 3917283)
Int J Immunopharmacol. 1985;7(1):57-64. (PMID: 3888868)
J Immunol. 1990 Jan 1;144(1):263-70. (PMID: 2104888)
J Immunol. 1980 May;124(5):2110-6. (PMID: 6245135)
J Immunol. 1984 Oct;133(4):2025-31. (PMID: 6206147)
Infect Immun. 1983 Dec;42(3):1116-25. (PMID: 6315591)
Immunology. 1983 Sep;50(1):35-41. (PMID: 6193056)
Trans R Soc Trop Med Hyg. 1978;72(4):431-2. (PMID: 212851)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
J Immunol. 1991 Jan 1;146(1):108-13. (PMID: 1845802)
Parasitol Res. 1991;77(7):572-6. (PMID: 1792226)
Infect Immun. 1990 Dec;58(12):3941-6. (PMID: 2123828)
J Leukoc Biol. 1989 Sep;46(3):270-4. (PMID: 2547889)
J Clin Immunol. 1983 Oct;3(4):295-315. (PMID: 6140268)
Biochem Biophys Res Commun. 1983 Jul 18;114(1):248-54. (PMID: 6309167)
J Immunol. 1984 Apr;132(4):1987-92. (PMID: 6321595)
J Immunol. 1984 Aug;133(2):764-8. (PMID: 6330202)
J Immunol. 1981 Jun;126(6):2084-6. (PMID: 6262406)
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887-91. (PMID: 6267608)
Mol Immunol. 1982 Oct;19(10):1287-96. (PMID: 6294507)
J Immunol. 1984 Apr;132(4):1851-7. (PMID: 6230395)
Immunology. 1980 Oct;41(2):347-52. (PMID: 6254869)
J Immunol. 1982 Mar;128(3):1458-65. (PMID: 6460061)
Fed Proc. 1983 Jan;42(1):129-33. (PMID: 6401250)
Am J Pathol. 1984 Feb;114(2):240-9. (PMID: 6582787)
J Immunol. 1988 May 1;140(9):3140-3. (PMID: 3129511)

0 (Antigens, Protozoan)
0 (SRS-A)
27YG812J1I (Arachidonic Acid)
K7Q1JQR04M (Dinoprostone)

Date Created: 19920601 Date Completed: 19920825 Latest Revision: 20181113

20240829

PMC1421539

1634248